Programme Category
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Identifier Code
Call
Summary
The European and Developing Countries Clinical Trials Partnership (EDCTP) has established itself as the focal point of cooperation in clinical research on infectious disease between the EU and sub-Saharan Africa. Τhere is a need to further support research on the major infectious disease threats facing sub-Saharan Africa. Despite large-scale investments in product development for poverty-related infectious diseases (PRDs), progress in achieving public health gain is slow, while sub-Saharan Africa bears the highest burden of these diseases. There is a need to support product development and to encourage the use of new, innovative approaches and emerging technologies in sub-Saharan Africa to achieve rapid progress and impact.
Detailed Call Description
Proposals should address all of the following:
- Any PRD disease or group of PRDs affecting sub-Saharan Africa.
- Combine health technologies with other scientific areas such as mobile technologies and digital technologies, big data processing, and other emerging technologies.
- Implement one or more medium-scale clinical trials and/or clinical research studies that can deliver the proof-of-concept or validate smart, highly innovative health technologies or concepts to prevent, treat or diagnose PRDs in sub-Saharan Africa, drawing lessons from the COVID-19 experience.
- Increase collaboration with investors in development cooperation and international partnerships to create solutions for improved development or delivery of medical interventions for vulnerable populations in low-resource settings.
- Proposals involving pharmaceutical companies and small- or medium-sized enterprises (SMEs) are encouraged.
- Develop solutions that are easily integrated or linked to existing electronic or digital systems that are used in the implementation of clinical research and health systems’ patient management.
- Include activities that promote collaboration with ongoing and future EDCTP projects. In this context the granting authority may share project-relevant information with the EDCTP Association and the future EDCTP3 Joint Undertaking.
- Promote the integration of research work and health care service delivery.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
EU contribution per project: € 8,00 million
Thematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- NGOs
- Non Profit Organisations
- Private Bodies
- Researchers/Research Centers/Institutions
- Small and Medium Enterprises (SMEs)
- State-owned Enterprises
Eligibility For Participation Notes
Legal entities established in all member states of the African Union are exceptionally eligible for Union funding.
The following additional eligibility criteria apply:
In order to achieve the expected objectives, namely that more clinicians and researchers in sub-Saharan Africa have the capacity to develop and design large-scale studies, the consortium must include at least one legal
entity established in a sub-Saharan African country (see p. 71 of the work programme).
Call Opening Date
Call Closing Date
National Contact Point(s)
Research and Innovation Foundation
Marinos Fotiadis
Contact Phone: 22 205 048
E-mail: mphotiades@research.org.cy
Website: https://www.research.org.cy/
Ioannis Theodorou
Contact Phone: 22 205 038
E-mail: itheodorou@research.org.cy
Website: https://www.research.org.cy/
(Publish Date: 03/08/2021-for internal use only)
EU Contact Point
European Commission, Directorate-General for Research and Innovation
https://ec.europa.eu/info/departments/research-and-innovation_en#contact